Encrantz Staffan 4

What Happened
Staffan Encrantz, a reported 10% owner of Sight Sciences (SGHT), purchased 14,100 shares of common stock in open‑market transactions on 2026‑06‑10. The reported weighted average price was $4.88 per share, for an aggregate purchase of approximately $68,794. This was a purchase (acquisition), which investors generally view as more informative than routine sales.

Key Details

• Transaction date: 2026-06-10 (Form 4 filed 2026-06-11). Transaction appears timely.
• Transaction type/code: P = Purchase (open market/private purchase).
• Shares acquired: 14,100 shares. Weighted average price: $4.88; total cost ≈ $68,794.
• Price range: per-share prices in the multiple trades ranged from $4.78 to $4.93; Encrantz can provide a breakdown on request (footnote F1).
• Reported holdings referenced in the filing: includes 1,406,022 shares of Common Stock and 28,261 restricted stock units (RSUs) — total cited = 1,434,283 (footnote F2).
• Record/beneficial ownership notes: some shares are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (Encrantz is a trustee) and by Allegro Investment Fund, L.P.; the filer disclaims certain beneficial ownership/pecuniary interests per footnotes F3 and F4.
• No indication of option exercise, gift, tax withholding, or 10b5-1 plan in this filing.

Context
Purchases by insiders can be taken as a positive signal, but for 10% owners (large shareholders or affiliated investors) trades may reflect personal or investment‑fund activity rather than executive views of near‑term company performance. This filing is straightforward: an open‑market acquisition reported the day after the trade.